医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

United Health Foundation Partners with Project HOPE to Mobilize Medical Care for Victims of Typhoon Haiyan

2013年11月16日 AM06:10
このエントリーをはてなブックマークに追加


 

MINNETONKA, Minn.

UnitedHealth Group’s (NYSE: UNH) United Health Foundation is partnering with Project HOPE, a U.S.-based charity, to help Filipinos affected by typhoon Haiyan receive urgent medical care and critical medical supplies. United Health Foundation and the employees of UnitedHealth Group have committed at least $750,000 to fund Project HOPE’s efforts.

Working in conjunction with the U.S. Navy, Project HOPE will deliver medical supplies, and assemble and deploy teams of volunteer nurses and physicians to disaster recovery sites in the Philippines to deliver critical medical care to people affected by the typhoon. United Health Foundation donations will directly fund the cost of delivering these teams to the Philippines.

“We are greatly saddened by the loss of life and immense destruction caused by typhoon Haiyan,” said Kate Rubin, vice president of Social Responsibility for UnitedHealth Group and president of United Health Foundation. “Given the scale of the disaster, there is an acute need for medical humanitarian assistance. By working with Project HOPE we will be able to help people get the necessary medical care, medicines and resources they need. Our hearts go out to the people of the Philippines.”

According to the Philippines government, more than 2,500 people lost their lives and an estimated 600,000 have been displaced from their homes as a result of typhoon Haiyan. It is the worst natural disaster in Philippines history.

About Project HOPE

Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world’s first peacetime hospital ship, Project HOPE now provides medical training and health education, as well as conducts humanitarian assistance programs in more than 35 countries. www.projecthope.org

About United Health Foundation

Guided by a passion to help people live healthier lives, United Health Foundation provides helpful information to support decisions that lead to better health outcomes and healthier communities. The Foundation also supports activities that expand access to quality health care services for those in challenging circumstances and partners with others to improve the wellbeing of communities. After its establishment by UnitedHealth Group [NYSE: UNH] in 1999 as a not-for-profit, private foundation, the Foundation has committed more than $210 million to improve health and health care. For additional information, please visit www.unitedhealthfoundation.org.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives and making health care work better. With headquarters in Minnetonka, Minn., UnitedHealth Group offers a broad spectrum of products and services through two business platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. Through its businesses, UnitedHealth Group serves more than 80 million people worldwide. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com.

Click here to subscribe to Mobile Alerts for UnitedHealth Group.

CONTACT

UnitedHealth Group
Dimitri Senaratna, 952-936-3275
dimitri_senaratna@uhg.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表